MX2021004179A - Metodo para preparar reactivos polimericos liberables. - Google Patents

Metodo para preparar reactivos polimericos liberables.

Info

Publication number
MX2021004179A
MX2021004179A MX2021004179A MX2021004179A MX2021004179A MX 2021004179 A MX2021004179 A MX 2021004179A MX 2021004179 A MX2021004179 A MX 2021004179A MX 2021004179 A MX2021004179 A MX 2021004179A MX 2021004179 A MX2021004179 A MX 2021004179A
Authority
MX
Mexico
Prior art keywords
polymeric reagents
fluorenyl
methods
based polymeric
prepared
Prior art date
Application number
MX2021004179A
Other languages
English (en)
Inventor
Sean M Culbertson
Samuel P Mcmanus
Antoni Kozlowski
Venkata Somu
Original Assignee
Nektar Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics filed Critical Nektar Therapeutics
Publication of MX2021004179A publication Critical patent/MX2021004179A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33331—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group
    • C08G65/33337—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing imide group cyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/46—Post-polymerisation treatment, e.g. recovery, purification, drying

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Polyethers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente solicitud proporciona (entre otras cosas) metodos mejorados para preparar reactivos polimericos basados en fluorenilo, metodos para recuperar y purificar tales reactivos polimericos, metodos para reducir impurezas no deseadas en un reactivo polimerico basado en fluorenilo, reactivos polimericos basados en fluorenilo preparados mediante los metodos descritos en la presente, y conjugados preparados por reaccion con reactivos polimericos basados en fluorenilo preparados mediante los metodos descritos en la presente.
MX2021004179A 2018-10-11 2019-10-11 Metodo para preparar reactivos polimericos liberables. MX2021004179A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862744512P 2018-10-11 2018-10-11
PCT/US2019/055971 WO2020077289A2 (en) 2018-10-11 2019-10-11 Method of making releasable polymeric reagents

Publications (1)

Publication Number Publication Date
MX2021004179A true MX2021004179A (es) 2021-09-08

Family

ID=68425321

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021004179A MX2021004179A (es) 2018-10-11 2019-10-11 Metodo para preparar reactivos polimericos liberables.

Country Status (9)

Country Link
US (1) US11932726B2 (es)
EP (1) EP3864068A2 (es)
JP (1) JP2022512627A (es)
KR (1) KR20210077677A (es)
CN (1) CN112839979B (es)
AU (1) AU2019358201A1 (es)
CA (1) CA3112834A1 (es)
MX (1) MX2021004179A (es)
WO (1) WO2020077289A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7269343B2 (ja) * 2019-07-01 2023-05-08 富士フイルム株式会社 光検出素子、光検出素子の製造方法、イメージセンサ、分散液および半導体膜

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629384A (en) 1994-05-17 1997-05-13 Consiglio Nazionale Delle Ricerche Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
MXPA02006215A (es) * 1999-12-22 2003-10-15 Nektar Therapeutics Al Corp Metodo para preparar esteres de 1-benzotriazolil carbonato de poli(etilenglicol).
US8604159B2 (en) 2003-07-22 2013-12-10 Nektar Therapeutics Method for preparing functionalized polymers from polymer alcohols
CN101242858B (zh) 2005-06-16 2012-12-19 尼克塔治疗公司 具有可降解键的轭合物以及用于制备这种轭合物的聚合物试剂
AU2006275473B2 (en) * 2005-07-29 2012-07-05 Nektar Therapeutics Methods for preparing carbonate esters of poly(ethylene glycol)
JP5096363B2 (ja) * 2005-12-16 2012-12-12 ネクター セラピューティックス Ｇｌｐ−１のポリマ複合体
US8268948B2 (en) * 2006-07-21 2012-09-18 Nektar Therapeutics Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom
US20130225789A1 (en) 2012-02-29 2013-08-29 Yi Sun Polyethylene Glycol Having Hetero Multiple Functional Groups
JP6784932B2 (ja) * 2015-03-31 2020-11-18 日油株式会社 生体機能性分子または薬物キャリアの化学修飾用生分解性ポリエチレングリコール誘導体

Also Published As

Publication number Publication date
US11932726B2 (en) 2024-03-19
JP2022512627A (ja) 2022-02-07
WO2020077289A3 (en) 2020-06-11
WO2020077289A2 (en) 2020-04-16
US20210388161A1 (en) 2021-12-16
AU2019358201A1 (en) 2021-05-20
KR20210077677A (ko) 2021-06-25
CN112839979A (zh) 2021-05-25
CN112839979B (zh) 2024-06-21
EP3864068A2 (en) 2021-08-18
CA3112834A1 (en) 2020-04-16

Similar Documents

Publication Publication Date Title
WO2019008123A3 (en) CELLS, VERTEBRATES, POPULATIONS AND METHODS
GB202101720D0 (en) Sars-cov-2 (sars2, covid-19) antibodies
MX2019011759A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando el mismo.
PH12019502171A1 (en) Composition and methods for immunooncology
MX2016000125A (es) Metodo de separacion de compuestos organofluorados utilizando membrana.
MX2023014027A (es) Proceso para la recuperacion selectiva de elementos del grupo calcofilo.
MX2020009416A (es) Nuevos reactivos a base de fosforo (v), procesos para su preparacion y su uso en la elaboracion de compuestos de organofosforo (v) estereo-definidos.
HK1074252A1 (en) Method for identifying and extracting endotoxin
WO2020061478A3 (en) Methods for purifying heterodimeric, multispecific antibodies
MX2021000153A (es) Dsba y dsbc ultrapurificado y métodos para elaborarlos y utilizarlos.
PH12018500150A1 (en) Microorganisms for producing putrescine or ornithine and process for producing putrescine or ornithine using them
MX2018006489A (es) Nanoemulsiones para bebidas producidas mediante un proceso de alto cizallamiento.
CR20200564A (es) Anticuerpos anti-tmeff2 monoespecificos y multiespecificos y sus usos
MX2016010027A (es) Proceso para la conversion biologica de bisulfuro en azufre elemental.
MX2019008241A (es) Un enlazador polipeptídico para preparar anticuerpos multispecíficos.
MX2021004179A (es) Metodo para preparar reactivos polimericos liberables.
MX2018001686A (es) Cisteinas de anticuerpo con capuchon y sin capuchon y su uso en conjugacion de anticuerpo-farmaco.
MX2018008351A (es) Metodos para preparar capsinoides por procesos biosinteticos.
PT2010544E (pt) Processo de preparação de dorzolamida
EA201071408A1 (ru) Способ получения однодольных растений с мужской стерильностью
MX2019015056A (es) Variante de acetohidroxiacido sintasa, microorganismo que comprende la misma, y procedimiento de produccion de aminoacidos de cadena l-ramificada mediante el uso del mismo.
ZA202104048B (en) Anti-il-17a antibody and use thereof
EA202191338A1 (ru) Улучшенный способ производства т-клеток
EA200970074A1 (ru) Химический способ создания давления
WO2019017612A3 (ko) 기능성 나노투과막이 수직적으로 고정된 마이크로칩 및 이의 제조방법